Skip to main content
main-content

17-02-2021 | ASCO GU 2021 | Conference coverage | Video

SPARTAN analysis finds molecular signatures that may predict response to apalutamide

Felix Feng discusses the implications of identifying molecular biomarkers of response to apalutamide in patients with nonmetastatic castration-resistant prostate cancer (5:18).

Read transcript

Image Credits